Susan Reed, MD, on the MsFLASH network's pooled findings, including nonhormonal therapies comparable to low-dose estradiol and CBT for sleep.
|Slideshows|August 29, 2019
5 steps to implementing an enhanced recovery pathway
Author(s)Amy N. Brown, MD, Bruce S. Kahn, MD, FACOG
As value in healthcare becomes an increasing priority for healthcare systems, ERPs will play a vital role in improving the care provided to patients.
Advertisement
Advertisement
Related to this article
Late recurrence, high-risk features, and treatment failure can signal midlife night sweats aren’t menopause, according to Cheryl Cox Kinney, MD.
Hormone therapy was associated with more frequent, longer migraines in postmenopausal women, but not with greater severity or analgesic use.
JoAnn V. Pinkerton, MD, offers primary care counseling on elinzanetant's side effects and the early onset and continued relief of hot flashes.
Menopausal brain fog is common, and hormone therapy has neutral cognitive effects, according to Pauline M. Maki, PhD.
Stephanie S. Faubion, MD, on choosing between fezolinetant and elinzanetant, liver monitoring, follow-up, and open questions in menopause care.
NK receptor antagonists significantly improved sleep disturbance in menopausal women at 4, 12, and 24 weeks in a meta-analysis of RCTs.
Perimenopausal women who were more physically active had significantly lower symptom burden across all domains, a study of 1808 Flo app users found.
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
Before Pregnancy Begins: Why the Timing of Carrier Screening Matters
2
Brain fog at menopause: Separating normal change from dementia
3
Neurokinin receptor antagonists improve menopausal sleep disturbance
4
Stephanie Faubion, MD, on the first menopause therapy discussion
5